First domestic company gets a first-in-class approval in China

China's National Medical Products Administration (NMPA) approved in May an NDA from Beijing Wenfeng

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE